NFKB1 and cancer: Cancer‐cell–derived lactate has also been reported to reprogram macrophages to a tumor‐prone phenotype by inhibiting the NF‐κB pathway that in turn may impair M1‐like activation and suppress the immune surveillance functions of infiltrating T cells and NK cells.142, 143, 144